Status | Study |
Not yet recruiting |
Study Name: The Occurence of Secondary Adrenal Insufficiency in Hospitalised Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene Condition: Adrenal Insufficiency Date: 2017-04-17 |
Recruiting |
Study Name: An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Condition: Plaque Psoriasis Date: 2016-10-12 Interventions: Drug: DSXS topical topical treatment Other Name: act |
Recruiting |
Study Name: An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. Condition: Atopic Dermatitis Date: 2016-10-12 Interventions: Drug: DSXS topical topical treatment Other Name: act |
Recruiting |
Study Name: Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS Condition: Psoriasis Date: 2016-10-11 Interventions: Drug: DSXS Topical product once daily for 28 days Ot |
Recruiting |
Study Name: An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris Condition: Acne Vulgaris Date: 2016-03-22 Interventions: Drug: cortexolone 17α-propionate CB-03-01 cream is a topical steroidal antiandrogen that is being d |
Recruiting |
Study Name: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis Condition: Dermatitis, Atopic Date: 2015-11-01 Interventions: Drug: DSXS Active treatment Other Name: Active |
Recruiting |
Study Name: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis Condition: Plaque Psoriasis Date: 2015-11-01 Interventions: Drug: DSXS twice daily for 28 days Other Name: Activ |
Completed |
Study Name: Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome Condition: Prader Willi Syndrome Adrenal Insufficiency Date: 2015-02-05 Interventions: Other: Low dose (1 mcg) ACTH stimulation test |
Recruiting |
Study Name: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis Condition: Plaque Psoriasis Date: 2014-12-28 Interventions: Drug: Topicort® (desoximetasone) Topical Spray, 0.25% Topicort® (desoximetasone) Topical Spray |
Completed |
Study Name: Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) Condition: Primary Adrenal Insufficiency Secondary Adrenal Insufficiency Date: 2014-10-24 Interventions: Drug: Plenadren Oral Tablets: |